ZA200709520B - Use of TFPI to treat severe bacterial infections - Google Patents

Use of TFPI to treat severe bacterial infections

Info

Publication number
ZA200709520B
ZA200709520B ZA200708936A ZA200709520A ZA200709520B ZA 200709520 B ZA200709520 B ZA 200709520B ZA 200708936 A ZA200708936 A ZA 200708936A ZA 200709520 A ZA200709520 A ZA 200709520A ZA 200709520 B ZA200709520 B ZA 200709520B
Authority
ZA
South Africa
Prior art keywords
tfpi
bacterial infections
treat severe
severe bacterial
treat
Prior art date
Application number
ZA200708936A
Other languages
English (en)
Inventor
Stephen Hardy
Yumin Dai
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200709520B publication Critical patent/ZA200709520B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ZA200708936A 2005-05-06 2007-11-05 Use of TFPI to treat severe bacterial infections ZA200709520B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67846505P 2005-05-06 2005-05-06
PCT/US2006/017956 WO2006122139A2 (en) 2005-05-06 2006-05-08 Use of tfpi to treat severe bacterial infections

Publications (1)

Publication Number Publication Date
ZA200709520B true ZA200709520B (en) 2008-11-26

Family

ID=37103012

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200708936A ZA200709520B (en) 2005-05-06 2007-11-05 Use of TFPI to treat severe bacterial infections

Country Status (16)

Country Link
US (1) US20090214506A1 (es)
EP (1) EP1877081A2 (es)
JP (1) JP2008540460A (es)
KR (1) KR20080017021A (es)
CN (1) CN101400365A (es)
AU (1) AU2006244053A1 (es)
BR (1) BRPI0611049A2 (es)
CA (1) CA2607293A1 (es)
IL (1) IL187111A0 (es)
MA (1) MA29489B1 (es)
MX (1) MX2007013876A (es)
NO (1) NO20076245L (es)
RU (1) RU2007145202A (es)
TN (1) TNSN07413A1 (es)
WO (1) WO2006122139A2 (es)
ZA (1) ZA200709520B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
WO2009129164A1 (en) * 2008-04-15 2009-10-22 Novartis Ag Pharmaceutical combinations of tfpi-fragments and an antibiotic
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US10457743B2 (en) 2013-07-19 2019-10-29 Novo Nordisk A/S Antibodies recognizing the N-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity
CN105777876B (zh) * 2016-05-26 2020-02-11 青岛农业大学 一种抗菌肽tc38及其应用
CN105777875B (zh) * 2016-05-26 2020-02-11 青岛农业大学 一种抗菌肽cstc24及其应用
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11572295B1 (en) * 2019-06-11 2023-02-07 Swamp Fox Innovations, LLC Compositions and methods for reduction of free chlorine and related odor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2463738A1 (en) * 2001-10-15 2003-07-10 Chiron Corporation Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
EP1654283B1 (en) * 2003-08-13 2011-07-13 Novartis Vaccines and Diagnostics, Inc. Improved method of purifying tfpi and tfpi analogs

Also Published As

Publication number Publication date
MA29489B1 (fr) 2008-05-02
RU2007145202A (ru) 2009-06-20
CN101400365A (zh) 2009-04-01
AU2006244053A1 (en) 2006-11-16
US20090214506A1 (en) 2009-08-27
KR20080017021A (ko) 2008-02-25
BRPI0611049A2 (pt) 2010-08-10
EP1877081A2 (en) 2008-01-16
WO2006122139A3 (en) 2007-04-26
JP2008540460A (ja) 2008-11-20
CA2607293A1 (en) 2006-11-16
MX2007013876A (es) 2008-04-02
WO2006122139A2 (en) 2006-11-16
NO20076245L (no) 2007-12-06
TNSN07413A1 (en) 2009-03-17
IL187111A0 (en) 2008-02-09

Similar Documents

Publication Publication Date Title
IL187111A0 (en) Use of tfpi to treat severe bacterial infections
EP1755661A4 (en) USE OF GELSOLINE FOR THE TREATMENT OF INFECTIONS
ZA200704392B (en) Antibiotic combinations for providing total solution to the treatment of infections
HK1134679A1 (zh) 用於治療感染的組合物和方法
SI1951272T1 (sl) Uporaba lactobacillus za zdravljenje virusnih infekcij
IL187999A0 (en) Compositions for the treatment of persistent infections
ZA200607889B (en) Dalbavancin compositions for treatment of bacterial infections
ZA200700420B (en) Methods of treatment of endobronchial infections
EP2069400A4 (en) METHOD FOR THE TREATMENT OF RSV INFECTIONS AND RELATED DISEASES
GB0513096D0 (en) Treatment of microbial infections
ZA201005798B (en) Treatment of microbial infections
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
LT2111855T (lt) Antibakteriės kompozicijos, skirtos viršutinių ir apatinių kvėpavimo takų infekcijų gydymui
IL180459A0 (en) Treatment of bacterial infections
ZA200704775B (en) Compositions for treatment of ear infections
PT1951374T (pt) Tratamento de infeções de bolsas subgengivais
GB0622841D0 (en) Treatment of staphylococcal infections
GB0622839D0 (en) Treatment of multi-drug resistant bacterial infections
GB0605035D0 (en) Improvements In Or Relating To The Treatment Of Orthopaedic Infections
AU2005903359A0 (en) Treatment of sheep to reduce flystrike
GB0711704D0 (en) Treatment of staphylococcal infections
GB0711703D0 (en) Treatment of multi-drug resistant bacterial infections
GB0801768D0 (en) Treatment of microbial infections